Healthcare Policy Program In The News

Medicare can be confusing—so many choices, so much jargon. Here is the type of plan to choose, according to Amitabh Chandra.

Many people choose the wrong plan simply because it all seems too complicated to understand. Op-ed: Amitabh Chandra.

Chandra, along with 17 Harvard faculty, is among 269 newly elected members of the American Academy of Arts & Sciences.

In this podcast, Amitabh Chandra discusses how the Inflation Reduction Act will impact biopharma innovation.

Retailer is good at finding efficiencies, improving customer experience, but there’s much more to it than that, says Amitabh Chandra in this Q&A with the Harvard Gazette.

7 experts try to answer who has the world’s best health-care system. Featured: Amitabh Chandra, Austin Frakt, Ashish Jha

A Rare Find in Health Care: A Simple Solution to Racial Inequity. Profiled: Amitabh Chandra.

More News

Wall Street Journal, Op-Ed, August 15, 2023
"Here’s a look at the mistakes people make all too often when selecting Medicare options, how they can make better choices—and which types of plans I recommend."

Wall Street Journal, Op-Ed, May 21, 2023
"The decision, which has enormous implications for our health and finances, is horrendously complex. And we are universally terrible at it."

Harvard Gazette, Q&A, August 10, 2022
“Amazon is good at selling other people’s products — but I don’t see it as a pharmaceutical company that might cure disease.”

Fortune Magazine, January 12, 2022
“If a lot of people are getting COVID despite being very careful, then I think the stigma of getting COVID-19 will fall substantially,” Chandra said. “The politics of the disease has changed.”

Fortune Magazine, January 10, 2022
“The problem right now is: If you get sick, you don’t have a paycheck. Trying to avoid getting sick, you don’t have a test that helps you avoid getting sick,” Amitabh Chandra, professor of Public Policy at Harvard Kennedy School, tells Fortune.

New York Times, December 22, 2021
“People are dropping drugs that keep them away from death and out of hospital,” said Amitabh Chandra, professor of public policy at the Harvard Kennedy School of Government and a co-author of the study.

Politico, September 29, 2021
It turns out, Harvard economist Amitabh Chandra says, that patients don’t really like to shop around after all. In research Chandra helped conduct on price transparency results, patients barely used the products — and often decided on higher-priced medical services.

Washington Post, June 17, 2021

HBS Working Knowledge, June 2, 2021
For the past 20 years, Chandra has been examining differences in health outcomes between white and Black Americans, searching for solutions to shrink the gap. In a recent working paper published through the National Bureau of Economic Research, he proposes one such solution: helping Black patients choose better-performing hospitals.

The New Yorker, April 15, 2021
It’s important, Chandra argues, for the government to consistently fund the creation of vaccines and other treatments, even if they end up not being used. “When it comes to something like vaccines, you don’t want the best deal,” he said. “You don’t want to pay the minimum price. You want to overpay and attract the attention of many companies simultaneously.”

Vox, February 10, 2021
“We find that small increases in cost cause patients to cut back on drugs with large benefits, ultimately causing their death,” the authors — Amitabh Chandra, Evan Flack, and Ziad Obermeyer — wrote."

Axios, February 9, 2021
Even a seemingly modest increase in out-of-pocket costs will cause many patients to stop taking drugs they need, according to a from Harvard economist Amitabh Chandra.

��vlog��